about
A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage formsNew developments in anti-malarial target candidate and product profilesDosage Form Data Used for Estimating Pediatric Antibiotic UseReview of paediatric gastrointestinal physiology data relevant to oral drug delivery.Population pharmacokinetics of levamisole in children with steroid-sensitive nephrotic syndromeAdvances in orodispersible films for drug delivery.Antiparasitic drugs for paediatrics: systematic review, formulations, pharmacokinetics, safety, efficacy and implications for control.Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases.Educational paper: formulation-related issues in pediatric clinical pharmacology.Oromucosal film preparations: classification and characterization methods.Pediatric drug development: formulation considerations.The role of formulation on the pharmacokinetics of antiretroviral drugs.Orally disintegrating films and mini-tablets-innovative dosage forms of choice for pediatric use.Physiologically Based Pharmacokinetic Modeling in Pediatric Oncology Drug Development.In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.Pediatric Dispersible Tablets: a Modular Approach for Rapid Prototyping.Pharmacokinetics of rabeprazole granules versus tablets, and the effect of food on the pharmacokinetics of rabeprazole granules in healthy adults-cross-study comparison.In vivo and in vitro palatability testing of a new paediatric formulation of valaciclovir.Synergistic effect of hydrotrope and surfactant on solubility and dissolution of atorvastatin calcium: screening factorial design followed by ratio optimizationIndividual oral therapy with immediate release and effervescent formulations delivered by the solid dosage pen.10 years EU regulation of pediatric medicines - impact on cardiovascular drug formulations.The Relative Bioavailability of Ibuprofen After Administration With a Novel Soft Chewable Drug Formulation.Risk assessment for extending the Biopharmaceutics Classification System-based biowaiver of immediate release dosage forms of fluconazole in adults to the paediatric population.Pediatric drug formulation of sodium benzoate extended-release granules.Bioequivalence of enalapril oral solution for treatment of pediatric hypertension and enalapril tablets.Micropellets coated with Kollicoat® Smartseal 30D for taste masking in liquid oral dosage forms.Patient-centered drug delivery and its potential applications for unmet medical needs.Organic-aqueous crossover coating process for the desmopressin orally disintegrating microparticles.
P2860
Q27027075-2874C0DF-DBDC-485C-84FC-7DF2BF3E3E27Q28468598-A13525B4-BF11-4E9C-A1B9-33F1FAF34B46Q31042501-D3A2B08F-98DE-486E-AF6F-D32D497F7EE9Q33834303-96C9C558-60A8-455C-BB26-2C11CB153D1FQ35972218-63B5A82A-510E-4210-87DE-09DDAA830773Q37834030-ED31BABF-64B2-4E3D-BC05-7FA9B0701E5EQ37846890-992F03CF-7D59-4B0D-9243-00AF3D6E9633Q37976848-A14FDA15-AF36-45A8-A47E-1D394EB3C8CDQ38056656-51039B7A-27D8-4E4B-BB5C-3265B2277F39Q38114516-5782EE16-2441-4737-9154-D17FB0D3931CQ38183868-4C4EC71F-162F-4467-A697-2BAB2ACB78CEQ38216047-E19B48BF-B68B-494C-A727-F7CD3CC356D2Q38367674-3B1A43A1-AF10-4633-B0B2-6D69CB178A7AQ38758820-A963E6FC-3848-47BB-9372-DA0E84781A6AQ39520757-E34D3D52-C204-45C8-8044-824AF056B955Q39717226-7E344490-F6D3-4476-B40D-0C0897CDF270Q39809735-53B87416-DE8B-40A6-B689-63DE27123CF9Q40097071-58473E4E-1716-4133-841E-3607A00E02A4Q42081544-E8CA8694-15E2-4545-A093-E1512DF08429Q43049836-A982F371-AEDD-4BCF-95CC-E1C8966DF503Q47760793-431E272E-E68B-4360-89BD-AED3105F6C47Q49614185-3DCD8C76-EBFB-431C-8F11-FD216842CEB4Q50593909-6B130804-841C-4CC9-9254-3717250ECB4DQ51018288-1E46DF44-0EB9-47CC-8C8D-B67FD11D3017Q51313450-04C0D319-467F-4774-93DB-CEC57671E3F0Q52839448-B37A32F3-DE72-4C7D-B575-D006FEAA5BA8Q53099408-CEE1F9A5-EBE2-487B-AD0F-3662878EF754Q53307774-38169F80-B49D-4074-8E7D-56C9CCCD96B6
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Paediatric and geriatric drug delivery.
@ast
Paediatric and geriatric drug delivery.
@en
type
label
Paediatric and geriatric drug delivery.
@ast
Paediatric and geriatric drug delivery.
@en
prefLabel
Paediatric and geriatric drug delivery.
@ast
Paediatric and geriatric drug delivery.
@en
P2860
P356
P1476
Paediatric and geriatric drug delivery.
@en
P2093
Joachim Boos
Jörg Breitkreutz
P2860
P356
10.1517/17425247.4.1.37
P407
P577
2007-01-01T00:00:00Z